about
The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancersSpanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decadeThe exposome: from concept to utilityEstrogen biology: new insights into GPER function and clinical opportunitiesGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicinePersonalized-detailed clinical model for data interoperability among clinical standardsTwo-way learning with one-way supervision for gene expression data.A comprehensive study of small non-frameshift insertions/deletions in proteins and prediction of their phenotypic effects by a machine learning method (KD4i).Two decades after BRCA: setting paradigms in personalized cancer care and preventionThe potential applications of Apolipoprotein E in personalized medicineEvaluating an Integrative Theoretical Framework for HIV Sexual Risk among Juvenile Justice involved Adolescents.Developing a framework for implementation of genetic services: learning from examples of testing for monogenic forms of common diseases.Biological aspects of early osteoarthritis.A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease.Proposal for a telehealth concept in the translational research modelHeterozygous mutations in DNA repair genes and hereditary breast cancer: a question of power.Toxicologic pathology in the 21st century.Personalized medicine and cancer.Longevity-associated mitochondrial DNA 5178 C/A polymorphism modulates the effects of coffee consumption on erythrocytic parameters in Japanese men: an exploratory cross-sectional analysis.A MEMS-Based Approach to Single Nucleotide Polymorphism GenotypingDiseaseComps: a metric that discovers similar diseases based upon common toxicogenomic profiles at CTD.Translating cancer 'omics' to improved outcomes.Biomarkers: symptoms, survivorship, and quality of lifeGene-Diet Interactions in Complex Disease: Current Findings and Relevance for Public Health.Clinical decision support for genetically guided personalized medicine: a systematic reviewIncorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physiciansFrom single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy.Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research.Genomic Biomarkers for Breast Cancer Risk.Patient compliance based on genetic medicine: a literature review.From "Personalized" to "Precision" Medicine: The Ethical and Social Implications of Rhetorical Reform in Genomic Medicine.Needs and Requirements of Modern Biobanks on the Example of Dystonia Syndromes.The role of the complement system in age-related macular degeneration.Metabolomics as a key integrator for "omic" advancement of personalized medicine and future therapies.Research ethics in the post-genomic era.Male breast cancer: genetics, epigenetics, and ethical aspects.Cancer genomics and inherited risk.Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review.Reads meet rotamers: structural biology in the age of deep sequencing.Recent patents and technology transfer for molecular diagnosis of β-thalassemia and other hemoglobinopathies.
P2860
Q26747403-58ED94AD-4C91-4FB5-8314-0BFD8E25DF2CQ26770333-1F46B7ED-8FDA-4F36-AFA7-6C7CC63ABFDBQ26821776-38A78774-A252-407B-80B5-A18BE6A8257EQ28307726-932E3BDB-53EB-451F-98C0-A909B4659B2CQ30513982-40FE31E3-7C20-46C3-9255-53BFAB524081Q30656638-997D4FD6-2116-41EF-A75F-E627A660A97DQ31170451-9B2A32FC-6774-43DA-81BD-0564A1306713Q33612884-DF609352-593B-4F5B-B9E1-565AD082D5C6Q33820594-B8D5F350-CD4D-4717-8CB8-770BA2C4787CQ33858831-CE77CCAF-6744-4652-9720-B253E21C07F7Q34026721-9841682D-C2CB-45D3-807B-5DADE268D1EFQ34156862-708A37C0-4DE1-42DA-8D44-E6B8E7D5EE8BQ34225355-1714A2D8-FD8B-4838-A48C-5A71ECD3C940Q34322438-11FE3753-D99F-4315-BC1B-186C25D3C6E9Q34386501-61FC2357-FC37-454D-BEB5-B2913A94FA00Q34426654-C52C0922-FA56-4C81-B52D-B3217B8C2A56Q34473377-8A99A67C-6241-41B1-B22F-754522A2DBA3Q34608577-BE93BE75-8BD2-4609-8A0F-2F2E927911A7Q35141228-2A33EE00-CFF5-4D99-9D58-8CA0AE51ECFCQ35147155-6E794EF6-220E-4A22-89D2-EA6A0372C3ADQ35562008-02C06F10-22C1-4D1F-96BC-A65088028B96Q35694365-6CF0F5CF-AA6A-4367-BC83-5B38E8C68470Q35923511-1CFD131A-8781-4439-82DA-5EEEA8E690B0Q36371895-232CCB91-61F4-4E0B-9CB1-DD804BA1590BQ36800565-DE282CC3-7494-4E13-A914-346FE874CCB3Q36935684-3282ADF9-9431-49FC-A37B-D33954211023Q37014982-642F9851-7AEC-486A-AEA8-76425B4263F2Q37238134-A826AA1C-70AC-4746-9ACE-E55D1EEB5693Q37242239-4BC65836-E496-49CF-A7C1-2641432572B0Q37471829-C84BDADE-4237-42CD-B347-1C407EDFA9A9Q37497641-2F81514C-6286-49F2-ABE8-D09963ECB8EEQ37611713-95EEC2F8-09BB-4370-9092-0ACE9DC160DFQ37646779-1308201D-C4BD-47ED-A7C7-2D317539BB64Q38017698-D5262E85-F3B7-4722-B6F7-AA36BEAF4073Q38125958-EF710C7A-2408-4873-823D-20B391DB6FB3Q38153187-AC50A85C-2690-45DA-AA0E-9C50267CCCA1Q38180646-75B435C8-CE79-4C27-8E74-165B8D96A685Q38211737-B358AC45-742A-44E6-92B0-5AAA318A757FQ38371193-FCF45E9C-B1F5-4214-9640-982E6A2EFDE8Q38594354-7C9BB3C4-4B92-4A86-944D-60EB32517FD5
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Personalized medicine: new genomics, old lessons
@ast
Personalized medicine: new genomics, old lessons
@en
type
label
Personalized medicine: new genomics, old lessons
@ast
Personalized medicine: new genomics, old lessons
@en
prefLabel
Personalized medicine: new genomics, old lessons
@ast
Personalized medicine: new genomics, old lessons
@en
P2860
P1433
P1476
Personalized medicine: new genomics, old lessons
@en
P2860
P2888
P356
10.1007/S00439-011-1028-3
P577
2011-06-26T00:00:00Z
2011-07-01T00:00:00Z